NirogStreet Revenue and Competitors
Employee Data
- NirogStreet has 290 Employees.
- NirogStreet grew their employee count by 44% last year.
NirogStreet's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & Founder | Reveal Email/Phone |
2 | Content Writer | Reveal Email/Phone |
3 | Advisor - Finance and Strategy : Nirogstreet Pte Ltd | Reveal Email/Phone |
4 | Ayurveda Head | Reveal Email/Phone |
NirogStreet Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 89 | 44% | N/A | N/A |
#2 | N/A | 906 | 30% | N/A | N/A |
#3 | N/A | 1017 | 7% | N/A | N/A |
#4 | $15M | 1266 | 9% | N/A | N/A |
#5 | N/A | 613 | 22% | N/A | N/A |
#6 | N/A | 290 | 44% | N/A | N/A |
What Is NirogStreet?
Nirogstreet as a concept is working to make #Ayurveda first call of treatment. We are organising supply chain of Ayurveda services and medicine to deliver the care that people trust.
keywords:N/AN/A
Total Funding
290
Number of Employees
N/A
Revenue (est)
44%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NirogStreet News
2022-04-17 - Global Ayush Investment & Innovation Summit: Cannabis meets Ayurveda at
Delhi-based Hempstreet Medicare
Nirogstreet allowed for online bookings and appointments of Ayurveda products as well as online purchases of Ayurveda medicines. Check Out...
2022-03-30 - [World Health Day] Meet 5 healthtech startups that are powering the future
of healthcare in India
Launched in 2016 in Gurugram by Ram N Kumar and Robin Jha, ?NirogStreet? is a B2B2C technology-enabled and doctor-led platform aimed at...
2022-03-22 - PM Modi applauds work done by NirogStreet in promoting ...
With technology-based interventions, NirogStreet enables doctors by giving technology to run their clinic, access to quality medicines inventory...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 291 | 14% | N/A |
#2 | N/A | 295 | 21% | N/A |
#3 | $32.8M | 295 | 69% | N/A |
#4 | $26.9M | 296 | 13% | N/A |
#5 | $22.9M | 297 | 5% | $863M |